U.S. FDA flags risk of heart inflammation after Novavax COVID vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. SKYD
9. MET
10. CRBU

Go back to U.S. FDA flags risk of heart inflammation after Novavax COVID vaccine

Novavax (NVAX) Shares Halted for News Pending Ahead of FDA Panel

June 7, 2022 6:55 AM EDT

Novavax (NASDAQ: NVAX) Shares Halted for News Pending Ahead of FDA Panel

... More

UPDATE: Cowen Reiterates $150 PT on Novavax (NVAX), Believes 'briefing documents suggest that the vaccine meets all the requirements for approval '

June 3, 2022 11:23 AM EDT

(Updated - June 3, 2022 11:24 AM EDT)

Cowen analyst Georgi Yordanov reiterated an Outperform rating and $150.00 price target on Novavax (NASDAQ: NVAX).

The analyst comments " Overall, we believe the briefing documents suggest that the vaccine meets all the requirements for approval and we expect a positive vote at next week's meeting. As for the timing of a potential approval, the Agency does highlight that Novavax is yet to... More